Investor relations at Salix
At Salix, we create value for our investors by developing & marketing innovative products that help diagnose or treat gastrointestinal disorders. Please browse this section to learn more about our financial performance.
If you do not find what you are looking for in this section, or if you require additional assistance, please contact:
G. Michael Freeman
Associate Vice President, Investor Relations & Corporate Communications